Table 4. Activity of Imipenem in Combination with pCMB and Mitoxantrone vs. BL21/VIM2 E. coli.
Imipenem + pCMB | Imipenem + Mitoxantrone | |||
---|---|---|---|---|
Imipenem MIC, μg/mL | p-CMB, μg/mL | Imipenem MIC, μg/mL | Mitoxantrone, μg/mL | |
MIC of Imipenem in Presence of Inhibitor, μg/mL | <0.1 | 35.8 | <0.1 | 66.9 |
<0.1 | 17.9 | <0.1 | 33.5 | |
0.1 | 8.9 | <0.1 | 16.7 | |
0.1 | 4.5 | <0.1 | 8.4 | |
0.5 | 2.2 | 0.2 | 4.2 | |
0.9 | 1.1 | 0.5 | 2.1 | |
1.9 | 0.6 | 0.5 | 1.0 | |
1.9 | 0.3 | 1.9 | 0.5 | |
1.9 | 0.1 | 1.9 | 0.3 | |
MIC alone, μg/mL | 1.9 | 17.9 | 1.9 | 8.4 |